Contact
Please use this form to send email to PR contact of this press release:
Immatics Announces Third Quarter 2024 Financial Results, Business Update and First Clinical Data on TCER® IMA402 Targeting PRAME
TO:
Please use this form to send email to PR contact of this press release:
Immatics Announces Third Quarter 2024 Financial Results, Business Update and First Clinical Data on TCER® IMA402 Targeting PRAME
TO: